Octenidine-based hydrogel shows anti-inflammatory and protease-inhibitory capacities in wounded human skin.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 01 2021
Historique:
received: 18 08 2020
accepted: 04 12 2020
entrez: 9 1 2021
pubmed: 10 1 2021
medline: 20 7 2021
Statut: epublish

Résumé

Octenidine dihydrochloride (OCT) is a widely used antiseptic molecule, promoting skin wound healing accompanied with improved scar quality after surgical procedures. However, the mechanisms by which OCT is contributing to tissue regeneration are not yet completely clear. In this study, we have used a superficial wound model by tape stripping of ex vivo human skin. Protein profiles of wounded skin biopsies treated with OCT-containing hydrogel and the released secretome were analyzed using liquid chromatography-mass spectrometry (LC-MS) and enzyme-linked immunosorbent assay (ELISA), respectively. Proteomics analysis of OCT-treated skin wounds revealed significant lower levels of key players in tissue remodeling as well as reepithelization after wounding such as pro-inflammatory cytokines (IL-8, IL-6) and matrix-metalloproteinases (MMP1, MMP2, MMP3, MMP9) when compared to controls. In addition, enzymatic activity of several released MMPs into culture supernatants was significantly lower in OCT-treated samples. Our data give insights on the mode of action based on which OCT positively influences wound healing and identified anti-inflammatory and protease-inhibitory activities of OCT.

Identifiants

pubmed: 33420112
doi: 10.1038/s41598-020-79378-9
pii: 10.1038/s41598-020-79378-9
pmc: PMC7794247
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Hydrogels 0
Imines 0
Protease Inhibitors 0
Pyridines 0
Peptide Hydrolases EC 3.4.-
octenidine OZE0372S5A

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

32

Références

Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Wound Repair Regen. 2017 Apr;25(2):164-176
pubmed: 28120405
Biomedicines. 2020 Apr 30;8(5):
pubmed: 32365896
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Annu Rev Biomed Eng. 2019 Jun 4;21:145-169
pubmed: 30822099
J Immunol Res. 2019 Mar 3;2019:5143635
pubmed: 30944833
J Plast Reconstr Aesthet Surg. 2010 Jun;63(6):1015-21
pubmed: 19464975
Exp Biol Med (Maywood). 2016 Dec;241(18):2033-2041
pubmed: 27207902
Int J Mol Sci. 2016 Dec 11;17(12):
pubmed: 27973441
Clin Microbiol Rev. 2019 Jul 31;32(4):
pubmed: 31366611
Nat Methods. 2017 May;14(5):513-520
pubmed: 28394336
Nucleic Acids Res. 2016 Jan 4;44(D1):D447-56
pubmed: 26527722
Int Wound J. 2018 Dec;15(6):914-920
pubmed: 29956471
Blood. 1999 Sep 15;94(6):2080-9
pubmed: 10477738
J Proteome Res. 2014 Dec 5;13(12):5989-6000
pubmed: 25347463
PLoS One. 2012;7(4):e32875
pubmed: 22485136
Proteomics. 2014 May;14(9):1006-0
pubmed: 24678027
Arthritis Res Ther. 2006;8 Suppl 2:S3
pubmed: 16899107
Int J Biochem Cell Biol. 2008;40(6-7):1334-47
pubmed: 18083622
FASEB J. 2018 Aug;32(8):4132-4144
pubmed: 29509510
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
Int Wound J. 2016 Apr;13(2):182-8
pubmed: 24589044
BMC Bioinformatics. 2012;13 Suppl 16:S12
pubmed: 23176165
J Antimicrob Chemother. 2010 Aug;65(8):1712-9
pubmed: 20551215
Anal Chem. 2017 Feb 7;89(3):1945-1954
pubmed: 28208246
J Wound Care. 2014 Mar;23(3):137-8, 140-2
pubmed: 24633059
J Invest Dermatol. 2009 Apr;129(4):851-61
pubmed: 19037237
J Invest Dermatol. 2013 Jun;133(6):1655-65
pubmed: 23325040
Nat Rev Immunol. 2009 Oct;9(10):679-91
pubmed: 19763149
Adv Wound Care (New Rochelle). 2015 Apr 1;4(4):225-234
pubmed: 25945285
Cell Tissue Res. 2013 Feb;351(2):255-68
pubmed: 22526628
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
J Invest Dermatol. 2007 Mar;127(3):514-25
pubmed: 17299434
Nucleic Acids Res. 2009 Jan;37(1):1-13
pubmed: 19033363
Nat Methods. 2009 May;6(5):359-62
pubmed: 19377485
Cytokine. 2000 Jun;12(6):671-6
pubmed: 10843743
Wound Repair Regen. 2000 May-Jun;8(3):216-25
pubmed: 10886812
Nat Methods. 2016 Sep;13(9):731-40
pubmed: 27348712
Clin Proteomics. 2018 Mar 9;15:13
pubmed: 29541007
Mol Cell Proteomics. 2016 Jun;15(6):1982-97
pubmed: 27025457
J Invest Dermatol. 2018 Oct;138(10):2095-2105.e1
pubmed: 30244718

Auteurs

Saskia Seiser (S)

Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Lukas Janker (L)

Department of Analytical Chemistry, University of Vienna, Vienna, Austria.
Joint Metabolome Facility, University of Vienna and Medical University of Vienna, Vienna, Austria.

Nina Zila (N)

Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Michael Mildner (M)

Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Ana Rakita (A)

Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Johannes Matiasek (J)

Department of Plastic, Aesthetic and Reconstructive Surgery, St. Josef Hospital, Vienna, Austria.

Andrea Bileck (A)

Department of Analytical Chemistry, University of Vienna, Vienna, Austria.
Joint Metabolome Facility, University of Vienna and Medical University of Vienna, Vienna, Austria.

Christopher Gerner (C)

Department of Analytical Chemistry, University of Vienna, Vienna, Austria.
Joint Metabolome Facility, University of Vienna and Medical University of Vienna, Vienna, Austria.

Verena Paulitschke (V)

Department of Dermatology, Medical University of Vienna, Vienna, Austria.

Adelheid Elbe-Bürger (A)

Department of Dermatology, Medical University of Vienna, Vienna, Austria. adelheid.elbe-buerger@meduniwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH